The cardiometabolic metabolic risk (CarMeR) study is a community-based cross-sectional study conducted using the WHO-STEPwise approach to identify and explain factors associated with cardiometabolic diseases.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.